Search This Blog

Wednesday, September 27, 2023

BrainStorm Cell Therapeutics Stock Trading Halted

 FDA advisory committee (ADCOM) meeting to review NurOwn® for ALS

https://finance.yahoo.com/news/brainstorm-cell-therapeutics-stock-trading-110000718.html

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)